← All Investors
ESPERION THERAPEUTICS INC
ESPR 4 11-15-25
Holders
0
Combined Value
$0
Combined Shares
0
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|
No tracked investors currently hold this security.
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q4 2025 | Howard Marks - Oaktree Capital | SOLD OUT | −$2.1M | ~$1.00 |
| Q3 2025 | Howard Marks - Oaktree Capital | BUY | +$649K | ~$1.00 |
| Q2 2025 | Howard Marks - Oaktree Capital | BUY | +$675K | ~$0.98 |
| Q1 2025 | Howard Marks - Oaktree Capital | NEW BUY | +$759K | ~$0.98 |
| Q3 2024 | Steve Cohen - Point72 | SOLD OUT | −$4.6M | ~$0.92 |
| Q3 2024 | Howard Marks - Oaktree Capital | SOLD OUT | −$2.3M | ~$0.93 |
| Q2 2024 | Steve Cohen - Point72 | NEW BUY | +$4.6M | ~$0.92 |
| Q2 2024 | Howard Marks - Oaktree Capital | NEW BUY | +$2.3M | ~$0.93 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q3 2025 | 1 | 2,114,000 | +44.5% | $2.1M | $1.00 |
| Q2 2025 | 1 | 1,463,000 | +89.0% | $1.4M | $0.98 |
| Q1 2025 | 1 | 774,000 | −89.7% | $759K | $0.98 |
| Q2 2024 | 2 | 7,495,000 | — | $6.9M | $0.93 |